A new 100% digital tool that manages Covid-19 risk assessments for employees returning to work or to international travel has been developed by Charles Taylor: providers of professional services and technology solutions to the global insurance market.

As Covid-19 restrictions are lifted, Venture, as the tool is known, will help businesses demonstrate that they have taken adequate risk assessment measures and implemented the right precautions to protect their staff: enabling the workforce to mobilise again in a safe and managed way.

Specifically, Venture identifies individual members of staff who are likely to develop severe symptoms of Covid-19. It gives employers a scale of risk, based on an employee’s predictive variables, so that the appropriate mitigation steps can be taken. Employees complete a brief online assessment, accessible from any device. 

Longer term, Venture can also identify globally mobile employees who may be susceptible to wider medical risks, beyond Covid-19.

HR, workplace, travel and compliance managers are among Venture’s many expected beneficiaries, in a variety of domestic and international settings, ranging from banks to supermarket chains and delivery companies to government departments.

Venture has been developed in consultation with Charles Taylor’s chief medical officer, Dr Lynn Gordon and Dr Paolo Paredi, honorary consultant and senior researcher at the National Heart and Lung Institute, Imperial College London. Powered by Charles Taylor’s online medical screening tool, Antidote, it draws on the provider’s 25 years’ experience of medical screening. 

The new tool ensures that employees’ sensitive medical information is withheld from their employers, while its technology can be configured to destination or employer-specific requirements. 

Angela Smith, head of proposition development for Charles Taylor Claims Solutions, comments, “Venture gives employers the reassurance they need to help staff return to the office or to resume international travel. It ensures that vulnerable individuals are identified accurately and fairly, based on their own individual health profiles – and this sets it apart from other broad-range Covid-risk-identification measures. 

Both Venture and our online medical screening tool, Antidote, can be integrated with the range of security and medical assistance services available from Charles Taylor; offering employers a comprehensive and tailored service that helps them meet and exceed their duty of care obligations.” 

David West, group IT director at Charles Taylor Insuretech, says, “Our online digital screening tool is another example of applying our technical insurance services knowledge and our technology expertise to bring practical and rapid benefit to our clients.  We are committed to expanding the range of insurance-specific technology solutions that we provide and to supporting the transformation of our clients and their services.”